Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis

BACKGROUND: Treatment of infective bronchitis involving Pseudomonas aeruginosa is a cornerstone of care in patients with cystic fibrosis (CF). This phase IIb, randomised, double-blind, placebo-controlled study assessed the efficacy and safety of ciprofloxacin dry powder for inhalation (DPI) in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorkin, Henry L, Staab, Doris, Operschall, Elisabeth, Alder, Jeff, Criollo, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680008/
https://www.ncbi.nlm.nih.gov/pubmed/26688732
http://dx.doi.org/10.1136/bmjresp-2015-000100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680008/
https://www.ncbi.nlm.nih.gov/pubmed/26688732
http://dx.doi.org/10.1136/bmjresp-2015-000100

Ejemplares similares